Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 247

1.

Boosting the social impact of innovative cancer research - towards a mission-oriented approach to cancer.

Ringborg U, Celis JE, Baumann M, Eggermont A, Wild CP, Berns A.

Mol Oncol. 2019 Mar;13(3):497-501. doi: 10.1002/1878-0261.12464. Epub 2019 Feb 27. No abstract available.

2.

Accumulation and potential sources of lead in marine organisms from coastal ecosystems of the Chilean Patagonia and Antarctic Peninsula area.

Espejo W, Padilha JA, Gonçalves RA, Dorneles PR, Barra R, Oliveira D, Malm O, Chiang G, Celis JE.

Mar Pollut Bull. 2019 Mar;140:60-64. doi: 10.1016/j.marpolbul.2019.01.026. Epub 2019 Jan 19.

PMID:
30803682
3.

Towards a mission-oriented approach to cancer in Europe: an unmet need in cancer research policy.

Celis JE, Heitor M.

Mol Oncol. 2019 Mar;13(3):502-510. doi: 10.1002/1878-0261.12452. Epub 2019 Feb 1. Review.

4.

Cancer Core Europe: A translational research infrastructure for a European mission on cancer.

Eggermont AMM, Apolone G, Baumann M, Caldas C, Celis JE, de Lorenzo F, Ernberg I, Ringborg U, Rowell J, Tabernero J, Voest E, Calvo F.

Mol Oncol. 2019 Mar;13(3):521-527. doi: 10.1002/1878-0261.12447. Epub 2019 Feb 2. Review.

5.

Trophic transfer of cadmium in marine food webs from Western Chilean Patagonia and Antarctica.

Espejo W, Padilha JA, Kidd KA, Dorneles PR, Barra R, Malm O, Chiang G, Celis JE.

Mar Pollut Bull. 2018 Dec;137:246-251. doi: 10.1016/j.marpolbul.2018.10.022. Epub 2018 Oct 16.

PMID:
30503432
6.

Welcome to our new Section Editors.

Celis JE.

Mol Oncol. 2018 Oct;12(10):1659-1660. doi: 10.1002/1878-0261.12380. No abstract available.

7.

European Academy of Cancer Sciences - position paper.

Adami HO, Berns A, Celis JE, de Vries E, Eggermont A, Harris A, Zur Hausen H, Pelicci PG, Ringborg U.

Mol Oncol. 2018 Nov;12(11):1829-1837. doi: 10.1002/1878-0261.12379. Epub 2018 Sep 21.

8.

Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century.

Calvo F, Apolone G, Baumann M, Caldas C, Celis JE, de Lorenzo F, Ernberg I, Ringborg U, Rowell J, Tabernero J, Voest E, Eggermont A.

Eur J Cancer. 2018 Nov;103:155-159. doi: 10.1016/j.ejca.2018.08.023. Epub 2018 Sep 18.

PMID:
30241002
9.

Thomas Tursz (1946-2018).

Ringborg U, Celis JE.

Mol Oncol. 2018 Sep;12(9):1413-1414. doi: 10.1002/1878-0261.12361. Epub 2018 Aug 2. No abstract available.

10.

A Global Overview of Exposure Levels and Biological Effects of Trace Elements in Penguins.

Espejo W, Celis JE, GonzÃlez-Acuña D, Banegas A, Barra R, Chiang G.

Rev Environ Contam Toxicol. 2018;245:1-64. doi: 10.1007/398_2017_5. Review.

PMID:
29079931
11.

A mission-oriented approach to cancer in Europe: a joint mission/vision 2030.

Celis JE, Pavalkis D.

Mol Oncol. 2017 Dec;11(12):1661-1672. doi: 10.1002/1878-0261.12143. Epub 2017 Nov 9.

12.

Molecular Oncology journal has moved to open access.

Celis JE, Moreira J.

Mol Oncol. 2017 Feb;11(2):123. doi: 10.1002/1878-0261.12031. No abstract available.

13.

Cancer Core Europe: a first step towards a virtual cancer institute in Europe?

Celis JE, Ringborg U.

Mol Oncol. 2014 Oct;8(7):1161-2. doi: 10.1016/j.molonc.2014.09.004. Epub 2014 Sep 18. No abstract available.

14.

Shaping science policy in Europe.

Celis JE, Gago JM.

Mol Oncol. 2014 May;8(3):447-57. doi: 10.1016/j.molonc.2014.03.013. Epub 2014 Mar 21.

15.

A personal account of the early stages of proteomics at Aarhus University.

Celis JE.

J Proteomics. 2014 Jul 31;107:31-8. doi: 10.1016/j.jprot.2014.01.021. Epub 2014 Jan 25.

PMID:
24473278
16.

Assessment of trace metals and porphyrins in excreta of Humboldt penguins (Spheniscus humboldti) in different locations of the northern coast of Chile.

Celis JE, Espejo W, González-Acuña D, Jara S, Barra R.

Environ Monit Assess. 2014 Mar;186(3):1815-24. doi: 10.1007/s10661-013-3495-6. Epub 2013 Oct 25.

PMID:
24464330
17.

Molecular Oncology. Editorial.

Celis JE.

Mol Oncol. 2013 Aug;7(4):739. doi: 10.1016/j.molonc.2013.07.003. Epub 2013 Jul 5. No abstract available.

18.

Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.

Cabezón T, Gromova I, Gromov P, Serizawa R, Timmermans Wielenga V, Kroman N, Celis JE, Moreira JM.

Mol Cell Proteomics. 2013 Feb;12(2):381-94. doi: 10.1074/mcp.M112.019786. Epub 2012 Nov 20.

19.

Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.

Moreira JM, Cabezón T, Gromova I, Gromov P, Timmermans-Wielenga V, Machado I, Llombart-Bosch A, Kroman N, Rank F, Celis JE.

Mol Oncol. 2010 Dec;4(6):539-61. doi: 10.1016/j.molonc.2010.09.005. Epub 2010 Oct 8.

20.

Challenges and opportunities in oncoproteomics.

Celis JE, Moreira JM.

Mol Oncol. 2010 Dec;4(6):459-60. doi: 10.1016/j.molonc.2010.10.001. Epub 2010 Oct 12. No abstract available.

21.

Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreira JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE.

Mol Oncol. 2010 Feb;4(1):65-89. doi: 10.1016/j.molonc.2009.11.003. Epub 2009 Nov 23.

22.

Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

Moreira JM, Ohlsson G, Gromov P, Simon R, Sauter G, Celis JE, Gromova I.

Mol Cell Proteomics. 2010 Jan;9(1):161-77. doi: 10.1074/mcp.M900294-MCP200. Epub 2009 Sep 25.

23.

Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Celis JE, Cabezón T, Moreira JM, Gromov P, Gromova I, Timmermans-Wielenga V, Iwase T, Akiyama F, Honma N, Rank F.

Mol Oncol. 2009 Jun;3(3):220-37. doi: 10.1016/j.molonc.2009.01.005. Epub 2009 Feb 3.

24.

'Tackling cancer in the EU: the role of innovation'.

Andrejevs G, Celis JE, Guidi G, Peterle A, Sullivan R, Wilson R.

Mol Oncol. 2009 Feb;3(1):18-23. doi: 10.1016/j.molonc.2008.12.003. Epub 2008 Dec 25.

25.

A single lysis solution for the analysis of tissue samples by different proteomic technologies.

Gromov P, Celis JE, Gromova I, Rank F, Timmermans-Wielenga V, Moreira JM.

Mol Oncol. 2008 Dec;2(4):368-79. doi: 10.1016/j.molonc.2008.09.003. Epub 2008 Oct 2.

26.

Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.

Li J, Gromov P, Gromova I, Moreira JM, Timmermans-Wielenga V, Rank F, Wang K, Li S, Li H, Wiuf C, Yang H, Zhang X, Bolund L, Celis JE.

Proteomics. 2008 Dec;8(23-24):5038-52. doi: 10.1002/pmic.200800303.

PMID:
19003862
27.

Clinical proteomics.

Celis JE, Moreira JM.

Mol Cell Proteomics. 2008 Oct;7(10):1779. doi: 10.1074/mcp.E800010-MCP200. No abstract available.

28.

15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.

Celis JE, Gromov P, Cabezón T, Moreira JM, Friis E, Jirström K, Llombart-Bosch A, Timmermans-Wielenga V, Rank F, Gromova I.

Mol Cell Proteomics. 2008 Oct;7(10):1795-809. doi: 10.1074/mcp.R800011-MCP200. Epub 2008 Jul 16.

29.

Proteomic strategies in bladder cancer: From tissue to fluid and back.

Gromov P, Moreira JM, Gromova I, Celis JE.

Proteomics Clin Appl. 2008 Jul;2(7-8):974-88. doi: 10.1002/prca.200780163. Epub 2008 Jul 10.

PMID:
21136898
30.

A combined proteome and ultrastructural localization analysis of 14-3-3 proteins in transformed human amnion (AMA) cells: definition of a framework to study isoform-specific differences.

Moreira JM, Shen T, Ohlsson G, Gromov P, Gromova I, Celis JE.

Mol Cell Proteomics. 2008 Jul;7(7):1225-40. doi: 10.1074/mcp.M700439-MCP200. Epub 2008 Mar 31.

31.

Human Proteinpedia enables sharing of human protein data.

Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL, Björling E, Blagoev B, Bose R, Brahmachari SK, Burlingame AS, Bustelo XR, Cagney G, Cantin GT, Cardasis HL, Celis JE, Chaerkady R, Chu F, Cole PA, Costello CE, Cotter RJ, Crockett D, DeLany JP, De Marzo AM, DeSouza LV, Deutsch EW, Dransfield E, Drewes G, Droit A, Dunn MJ, Elenitoba-Johnson K, Ewing RM, Van Eyk J, Faca V, Falkner J, Fang X, Fenselau C, Figeys D, Gagné P, Gelfi C, Gevaert K, Gimble JM, Gnad F, Goel R, Gromov P, Hanash SM, Hancock WS, Harsha HC, Hart G, Hays F, He F, Hebbar P, Helsens K, Hermeking H, Hide W, Hjernø K, Hochstrasser DF, Hofmann O, Horn DM, Hruban RH, Ibarrola N, James P, Jensen ON, Jensen PH, Jung P, Kandasamy K, Kheterpal I, Kikuno RF, Korf U, Körner R, Kuster B, Kwon MS, Lee HJ, Lee YJ, Lefevre M, Lehvaslaiho M, Lescuyer P, Levander F, Lim MS, Löbke C, Loo JA, Mann M, Martens L, Martinez-Heredia J, McComb M, McRedmond J, Mehrle A, Menon R, Miller CA, Mischak H, Mohan SS, Mohmood R, Molina H, Moran MF, Morgan JD, Moritz R, Morzel M, Muddiman DC, Nalli A, Navarro JD, Neubert TA, Ohara O, Oliva R, Omenn GS, Oyama M, Paik YK, Pennington K, Pepperkok R, Periaswamy B, Petricoin EF, Poirier GG, Prasad TS, Purvine SO, Rahiman BA, Ramachandran P, Ramachandra YL, Rice RH, Rick J, Ronnholm RH, Salonen J, Sanchez JC, Sayd T, Seshi B, Shankari K, Sheng SJ, Shetty V, Shivakumar K, Simpson RJ, Sirdeshmukh R, Siu KW, Smith JC, Smith RD, States DJ, Sugano S, Sullivan M, Superti-Furga G, Takatalo M, Thongboonkerd V, Trinidad JC, Uhlen M, Vandekerckhove J, Vasilescu J, Veenstra TD, Vidal-Taboada JM, Vihinen M, Wait R, Wang X, Wiemann S, Wu B, Xu T, Yates JR, Zhong J, Zhou M, Zhu Y, Zurbig P, Pandey A.

Nat Biotechnol. 2008 Feb;26(2):164-7. doi: 10.1038/nbt0208-164. No abstract available.

32.

Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

Celis JE, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans-Wielenga V, Rank F, Moreira JM.

Mol Oncol. 2007 Dec;1(3):321-49. doi: 10.1016/j.molonc.2007.09.004. Epub 2007 Sep 25.

33.

[Pathogenesis of breast cancer].

Petersen OW, Celis JE.

Ugeskr Laeger. 2007 Sep 3;169(36):2968-72. Review. Danish.

PMID:
17953870
34.

Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer.

Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N.

Int J Cancer. 2007 Oct 1;121(7):1433-44.

35.

Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Celis JE, Moreira JM, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, Rank F.

Mol Oncol. 2007 Jun;1(1):97-119. doi: 10.1016/j.molonc.2007.02.005. Epub 2007 Mar 14.

36.

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

Celis JE, Gromova I, Gromov P, Moreira JM, Cabezón T, Friis E, Rank F.

FEBS Lett. 2006 May 22;580(12):2935-44. Epub 2006 Apr 12. Review.

37.

Analysis of aerosol particles and coarse particulate matter concentrations in Chillán, Chile, 2001-2003.

Celis JE, Flocchini RG, Carvacho OF, Morales JR, Zaror CA, Inzunza JC, Pineda MJ.

J Air Waste Manag Assoc. 2006 Feb;56(2):152-8.

PMID:
16568798
38.

Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.

Celis JE, Gromov P, Moreira JM, Cabezón T, Friis E, Vejborg IM, Proess G, Rank F, Gromova I.

Mol Cell Proteomics. 2006 Mar;5(3):462-83. Epub 2005 Nov 28.

39.

Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas.

Ohlsson G, Moreira JM, Gromov P, Sauter G, Celis JE.

Mol Cell Proteomics. 2005 Apr;4(4):570-81. Epub 2005 Feb 25.

41.

Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.

Moreira JM, Ohlsson G, Rank FE, Celis JE.

Mol Cell Proteomics. 2005 Apr;4(4):555-69. Epub 2005 Jan 11.

42.

Towards discovery-driven translational research in breast cancer.

Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, Straten PT, Mouridsen H, Friis E, Holm D, Rank F, Gromov P.

FEBS J. 2005 Jan;272(1):2-15. Review.

43.

Gel-based proteomics: what does MCP expect?

Celis JE.

Mol Cell Proteomics. 2004 Oct;3(10):949. No abstract available.

44.

Impact of proteomics on bladder cancer research.

Celis JE, Gromova I, Moreira JM, Cabezon T, Gromov P.

Pharmacogenomics. 2004 Jun;5(4):381-94. Review.

PMID:
15165174
45.

Promoting basic research in Europe.

Celis JE.

FEBS Lett. 2004 Apr 9;563(1-3):1-2. No abstract available.

46.
47.

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Celis JE, Gromov P, Cabezón T, Moreira JM, Ambartsumian N, Sandelin K, Rank F, Gromova I.

Mol Cell Proteomics. 2004 Apr;3(4):327-44. Epub 2004 Jan 30.

49.

A European Research Council for all sciences: a dream that may come true.

Celis JE.

FEBS Lett. 2003 Dec 4;555(2):179. No abstract available.

50.

A study of the particulate matter PM10 composition in the atmosphere of Chillán, Chile.

Celis JE, Morales JR, Zaror CA, Inzunza JC.

Chemosphere. 2004 Jan;54(4):541-50.

PMID:
14581056

Supplemental Content

Loading ...
Support Center